MicroPort Scientific (FRA:MSK) Ending Cash Position: €582.9 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MSK MicroPort Scientific Corp FRA:MSK
75 GF Score
Price €0.74
GF Value €0.98
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is MicroPort Scientific Ending Cash Position?

MicroPort Scientific FRA:MSK +1.38% 75 Ending Cash Position is €582.9 Mil as of Dec. 2025. GuruFocus rates FRA:MSK with a GF Score™ of 75/100 and a GF Value™ of €0.98 (Modestly Undervalued). The stock has 9 warning signs investors should review.

MicroPort Scientific's Ending Cash Position for the quarter that ended in Dec. 2025 was €582.9 Mil.

MicroPort Scientific's quarterly Ending Cash Position declined from Dec. 2024 (€680.9 Mil) to Jun. 2025 (€662.8 Mil) and declined from Jun. 2025 (€662.8 Mil) to Dec. 2025 (€582.9 Mil).

MicroPort Scientific's annual Ending Cash Position declined from Dec. 2023 (€934.9 Mil) to Dec. 2024 (€680.9 Mil) and declined from Dec. 2024 (€680.9 Mil) to Dec. 2025 (€582.9 Mil).

MicroPort Scientific Ending Cash Position Related Terms

MicroPort Scientific Ending Cash Position Historical Data

* Premium members only.

The historical data trend for MicroPort Scientific's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroPort Scientific Ending Cash Position Chart

MicroPort Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,552.66 1,135.64 934.93 680.91 582.86

MicroPort Scientific Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 934.93 687.55 680.91 662.82 582.86
FRA:MSK
75GF Score
MicroPort Scientific Corp FRA:MSK
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MicroPort Scientific Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

MicroPort Scientific's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=608.898+-26.036
=582.9

MicroPort Scientific's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=652.881+-70.019
=582.9

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €582.9 Mil mean?
MicroPort Scientific (FRA:MSK) has a Ending Cash Position of €582.9 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on MicroPort Scientific and its competitors.
Is MicroPort Scientific's Ending Cash Position too high?
MicroPort Scientific's current Ending Cash Position is €582.9 Mil. Overall, MicroPort Scientific has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MicroPort Scientific's Ending Cash Position compare to ABT and SYK?
MicroPort Scientific's Ending Cash Position of €582.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on MicroPort Scientific and its competitors. MicroPort Scientific's current Ending Cash Position is €582.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort Scientific stock overvalued right now?
Based on GuruFocus' analysis, MicroPort Scientific (FRA:MSK) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.98, compared to a current price of €0.74 — trading 25% below its estimated fair value. The current Ending Cash Position is €582.9 Mil. MicroPort Scientific's overall GF Score™ is 75/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For MicroPort Scientific (FRA:MSK), the current Ending Cash Position is €582.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MicroPort Scientific (FRA:MSK) Overvalued in 2026?

Based on GuruFocus' analysis, MicroPort Scientific stock appears to be undervalued. The current stock price of €0.74 is trading 25% below its estimated GF Value™ of €0.98. GuruFocus considers MicroPort Scientific to be Modestly Undervalued.

Key valuation signals for FRA:MSK:

  • Ending Cash Position: €582.9 Mil
  • GF Value™: €0.98 vs. price of €0.74 (25% below fair value)
  • GF Score™: 75/100 with 9 warning signs

No single metric tells the full story. See the FRA:MSK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MicroPort Scientific Business Description

Other Exchanges MCRPF:USA00853:Hong Kong
Address 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, CHN, 201203
MicroPort Scientific Corp develops & markets medical devices in eight segments. Cardiovascular devices business: sales, manufacturing, & R&D of cardiovascular devices like drug-eluting stents. Orthopedics devices business: sales, manufacturing, R&D of orthopedics devices. CRM business: sales, manufacturing, R&D of cardiac rhythm management devices. Endovascular & peripheral vascular devices business: sales, manufacturing, R&D of endovascular & peripheral vascular devices. Neurovascular devices business: sales, manufacturing, R&D of neurovascular devices. Structural heart disease business: sales, manufacturing, R&D of heart valve devices. Surgical robot business: sales, manufacturing, & R&D of surgical robot devices. Surgical devices business: sales, manufacturing, R&D of surgical devices.
75GF Score

Get the complete analysis for FRA:MSK

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.74
Price
€0.98
GF Value